Clinical Trial Update: VXM01 Phase I Dose Escalation Study in Patients With Locally Advanced, Inoperable and Stage IV Pancreatic Cancer [Phase 1]

View source ↗

Summary

Results from a Phase I dose-escalation study of VXM01 in patients with locally advanced, inoperable, or Stage IV pancreatic cancer have been reported. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• VXM01

Snippet

Sponsor: Vaximm GmbH | Conditions: Stage IV Pancreatic Cancer | Phase 1 | Status: COMPLETED